series-a
Stage
1
Investors
About
nChroma Bio is a genetic medicines company that develops programmable in vivo delivery technologies combined with gene-regulating cargos to create targeted, durable therapies, primarily focusing on liver-directed treatments for chronic hepatitis B and other diseases.
Explore nChroma Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.